If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Medical Affairs » Health Outcomes
Download FREE Excerpt
9 Info Graphics
41 Data Graphics
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
In response, pharmaceutical and medical device companies are taking rapid steps to increase the precision and speed of their RWE capabilities. This critical trend is evident in the actions taken by Medical Affairs functions across the industry, which are quickly adopting more formal RWE processes, pursuing innovation, building the total data package, and utilizing RWE earlier in the product lifecycle.
This research examine how Medical Affairs teams from leading pharmaceutical and medical device companies are using real world evidence to achieve maximum impact along patient, disease state, clinical, payer and other value fronts.
This report evaluates the role of Medical Affairs in RWE strategic decision making, oversight, evidence gap assessment, and interpretation of medical and clinical value of health outcomes. The report also delivers benchmarks around real world data sources, collection, evaluation, utilization, evidence generation, investment, and overall key performance indicators.
Best Practices, LLC engaged 45 Medical Affairs and RWE leaders from 36 companies in this research through a benchmarking survey, interviews, and a roundtable meeting discussion.
Key topics covered in this report include: